Or. Admin. R. 333-007-0345

Current through Register Vol. 63, No. 6, June 1, 2024

Section 333-007-0345 - Compliance Testing Requirements for Cannabinoid Products

(1) A processor or processing site must test every process lot of a finished cannabinoid product intended for human consumption, use or ingestion for use by a consumer or patient prior to selling or transferring the cannabinoid product for THC and CBD concentration in accordance with OAR 333-007-0430.

(2) A processor or processing site must test a process lot of a finished cannabinoid product intended for human consumption, use or ingestion for microbiological contaminants in accordance with OAR 333-007-0390, upon written request by the Authority or the Commission.

(3) In lieu of ordering and arranging for the sampling and testing required in this rule a processor may transport batches of cannabinoid products referenced in section (1) of this rule to a wholesaler licensed by the Commission under ORS 475B.100 and the wholesaler may order and arrange for the sampling and testing of the batches, in accordance with rules established by the Commission.

Or. Admin. R. 333-007-0345

PH 21-2016, f. 6-24-16, cert. ef. 6/28/2016; PH 9-2017, f. 5-26-17, cert. ef. 5/31/2017; PH 282-2018, amend filed 12/20/2018, effective 1/1/2019

Statutory/Other Authority: ORS 475B.555

Statutes/Other Implemented: ORS 475B.555